271 related articles for article (PubMed ID: 28838228)
1. Red blood cell distribution width is useful in discriminating adult onset Still's disease and sepsis within 24 hours after hospitalization.
Park HJ; Song J; Park YB; Lee SK; Lee SW
Korean J Intern Med; 2018 Nov; 33(6):1234-1240. PubMed ID: 28838228
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 18: a biomarker for differential diagnosis between adult-onset Still's disease and sepsis.
Priori R; Colafrancesco S; Alessandri C; Minniti A; Perricone C; Iaiani G; Palazzo D; Valesini G
J Rheumatol; 2014 Jun; 41(6):1118-23. PubMed ID: 24786926
[TBL] [Abstract][Full Text] [Related]
3. Serum Heparin-Binding Protein as a Potential Biomarker to Distinguish Adult-Onset Still's Disease From Sepsis.
Tian R; Chen X; Yang C; Teng J; Qu H; Liu HL
Front Immunol; 2021; 12():654811. PubMed ID: 33868298
[TBL] [Abstract][Full Text] [Related]
4. Biomarker screening and validation for the differentiation of bloodstream infection from adult-onset Still's disease: A prospective cohort study.
Zhang W; Yang T; Zhang H; Xu Y; Yang Q; Liu Q; Gao Y; Wu J; Shao L; Zhang W
Cytokine; 2021 Oct; 146():155642. PubMed ID: 34325118
[TBL] [Abstract][Full Text] [Related]
5. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
Front Immunol; 2018; 9():3099. PubMed ID: 30687316
[TBL] [Abstract][Full Text] [Related]
6. Delta neutrophil index as an early marker for differential diagnosis of adult-onset Still's disease and sepsis.
Park HJ; Ha YJ; Pyo JY; Park YB; Lee SK; Lee SW
Yonsei Med J; 2014 May; 55(3):753-9. PubMed ID: 24719144
[TBL] [Abstract][Full Text] [Related]
7. Platelet parameters aid identification of adult-onset Still's disease from sepsis.
Liu JP; Wang YM; Zhou J
Neth J Med; 2019 Oct; 77(8):274-279. PubMed ID: 31814574
[TBL] [Abstract][Full Text] [Related]
8. Clinical manifestations but not cytokine profiles differentiate adult-onset Still's disease and sepsis.
Rau M; Schiller M; Krienke S; Heyder P; Lorenz H; Blank N
J Rheumatol; 2010 Nov; 37(11):2369-76. PubMed ID: 20810496
[TBL] [Abstract][Full Text] [Related]
9. Serum S100A12 may be a useful biomarker of disease activity in adult-onset Still's disease.
Bae CB; Suh CH; An JM; Jung JY; Jeon JY; Nam JY; Kim HA
J Rheumatol; 2014 Dec; 41(12):2403-8. PubMed ID: 25274901
[TBL] [Abstract][Full Text] [Related]
10. Combination value of biomarkers in discriminating adult onset Still's disease and sepsis.
Zhang M; Xie M; Wang Y; Li J; Zhou J
Wien Klin Wochenschr; 2021 Feb; 133(3-4):118-122. PubMed ID: 32430612
[TBL] [Abstract][Full Text] [Related]
11. Adult-onset Still's disease presenting as fever of unknown origin: a single-center retrospective observational study from China.
Zhang M; Wang Y; Li J; Zhou J
Ann Palliat Med; 2020 Sep; 9(5):2786-2792. PubMed ID: 32921079
[TBL] [Abstract][Full Text] [Related]
12. Serum S100A8/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease.
Kim HA; An JM; Nam JY; Jeon JY; Suh CH
J Rheumatol; 2012 Jul; 39(7):1399-406. PubMed ID: 22660800
[TBL] [Abstract][Full Text] [Related]
13. Adult-onset Still's disease: still a diagnosis of exclusion. A nested case-control study in patients with fever of unknown origin.
Vanderschueren S; Hermans F; De Munter P; Knockaert D
Clin Exp Rheumatol; 2012; 30(4):514-9. PubMed ID: 22510428
[TBL] [Abstract][Full Text] [Related]
14. The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still's disease.
Chen DY; Chen YM; Lin CC; Hsieh CW; Wu YC; Hung WT; Chen HH; Lan JL
BMC Musculoskelet Disord; 2015 May; 16():111. PubMed ID: 25956266
[TBL] [Abstract][Full Text] [Related]
15. Beneficial use of serum ferritin and heme oxygenase-1 as biomarkers in adult-onset Still's disease: A multicenter retrospective study.
Kirino Y; Kawaguchi Y; Tada Y; Tsukamoto H; Ota T; Iwamoto M; Takahashi H; Nagasawa K; Takei S; Horiuchi T; Ichida H; Minota S; Ueda A; Ohta A; Ishigatsubo Y
Mod Rheumatol; 2018 Sep; 28(5):858-864. PubMed ID: 29278009
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-37 is increased in adult-onset Still's disease and associated with disease activity.
Chi H; Liu D; Sun Y; Hu Q; Liu H; Cheng X; Ye J; Shi H; Yin Y; Liu M; Wu X; Zhou Z; Teng J; Yang C; Su Y
Arthritis Res Ther; 2018 Mar; 20(1):54. PubMed ID: 29566725
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still's disease.
Jung KH; Kim JJ; Lee JS; Park W; Kim TH; Jun JB; Yoo DH
Scand J Rheumatol; 2014; 43(2):162-9. PubMed ID: 24134323
[TBL] [Abstract][Full Text] [Related]
18. Serum calprotectin--a promising diagnostic marker for adult-onset Still's disease.
Guo Q; Zha X; Li C; Jia Y; Zhu L; Guo J; Su Y
Clin Rheumatol; 2016 Jan; 35(1):73-9. PubMed ID: 26547221
[TBL] [Abstract][Full Text] [Related]
19. [Still's syndrome in the adult (adult-onset Still's disease). 2 case reports and review of the literature].
Hippke WE; Blasum CP; Barth J
Hautarzt; 1994 Oct; 45(10):711-5. PubMed ID: 8002340
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-18 and fibroblast growth factor 2 in combination is a useful diagnostic biomarker to distinguish adult-onset Still's disease from sepsis.
Koga T; Sumiyoshi R; Furukawa K; Sato S; Migita K; Shimizu T; Umeda M; Endo Y; Fukui S; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Nonaka F; Yachie A; Kondo H; Maeda T; Kawakami A
Arthritis Res Ther; 2020 May; 22(1):108. PubMed ID: 32381117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
